Viking Therapeutics Inc
Biotechnology
Healthcare
VKTX
112 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
26.45
52 week high
78.03
high
26.64
52 week low
0.00
low
24.95
growth
-64.57 %
previous Close
26.25
P/E ratio
market cap
3.17 B
div yield
0
net incoming
-45.63 M
-28.83 %
net profit margin
-4562900000.00 %
0.00 %
operating incoming
-55.47 M
-19.96 %
net change in cash
11.26 M
147.59 %
cash on hand
37.94 M
42.23 %
top